- Antiphospholipid and Antinuclear Antibodies in Children with Idiopathic Epilepsy: A 2-Year Prospective Study
-
Attilakos , Fotis L, Dinopoulos A, Alexopoulos H, Theofilopoulou AV, Tzioufas A, Mastroyianni S, Karalexi M, Garoufi A
- KMID: 2467796
- J Clin Neurol.
- 2020 Jan;16(1):140-144.
- doi: 10.3988/jcn.2020.16.1.140
BACKGROUND AND PURPOSE: The high prevalence of antiphospholipid antibodies (aPL) and antinuclear antibodies (ANA) in patients with epilepsy may be associated with either the disease itself or the antiepileptic treatment.... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study
-
Attilakos , Paschalidou M, Garoufi A, Tsirouda M, Papadopoulou A, Karalexi M, Dinopoulos A
- KMID: 2467727
- J Clin Neurol.
- 2019 Apr;15(2):149-151.
- doi: 10.3988/jcn.2019.15.2.149
BACKGROUND AND PURPOSE: Long-term treatment with some older antiepileptic drugs may lead to hyperhomocysteinemia. Levetiracetam (LEV) is a newer broad-spectrum antiepileptic agent whose effects on homocysteine concentrations remain unclear. The... -
- CITED
-
- Close
- SHARE
-
- Close
